117 Broadway
Unit 4
Nedlands, WA 6009
Australia
61 8 9329 3396
https://argenica.com.au
版塊: Healthcare
行業: Biotechnology
全職員工:
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Dr. Liz Dallimore B.Sc., M.B.A., Ph.D. | CEO, MD & Director | 276.25k | 無 | 無 |
Ms. Emma Waldon | CFO & Company Secretary | 無 | 無 | 1976 |
Prof. Bruno Philip Meloni | Chief Scientific Officer | 無 | 無 | 無 |
Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.
截至 無 止,Argenica Therapeutics Limited 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。